CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it will be presenting at the 26th Annual JPMorgan Healthcare Conference on Monday January 7, 2008 at 1:30 pm PST in San Francisco. Sirtris will discuss the Company’s strategy for discovering and developing first-in-class therapeutics that modulate sirtuins, a recently discovered class of enzymes that control the aging process, as well as the Company’s clinical progress. The presentation will be webcast live and can be accessed on the Sirtris website, www.sirtrispharma.com, in the investor relations section. A replay will be available approximately twenty-four hours after the presentation and will be archived on the Company’s website for two weeks.
